Trial Profile
A retrospective, observational study to evaluate increased bone mineral density in postmenopausal women with osteoporosis receiving denosumab.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Dec 2016
Price :
$35
*
At a glance
- Drugs Denosumab (Primary)
- Indications Osteoporosis
- Focus Therapeutic Use
- 17 Dec 2016 Results of real-world chart review (n=222) study published in the Drugs in R and D
- 21 Aug 2015 New trial record